But in HL-60 NANOG activated the expression of transcription factor FOXC1 as described recently in AML patients and was additionally associated in NOMO-1 with FLT3-deregulation, which may play a supporting role in leukemogenesis as well [33,69]. The gene discussed is FLT3; the disease is acute myeloid leukemia.